Blog

In this article, ahead of the publication of the final report of the Grenfell Tower Inquiry, Steve Tombs gives three observations on the Inquiry and the likely import of its final report.

In this article, Sharon Hartles explores the ongoing challenges that Primodos survivors encounter in seeking justice. She discusses the impact of new evidence and advocacy efforts, highlighting the resilience of those involved in the quest for accountability. Sharon Hartles is a member of the Harm and Evidence Research Collaborative at the Open University. Additionally, she is affiliated with the Risky Hormones research project, an international collaboration in partnership with patient groups.

Increasing demands for greater intellectual diversity have drawn attention to the under representation of racially minoritised groups in UK higher education institutions (HEIs). However, as this post explores, there is much more that British universities can do to improve recruitment experiences for racially minoritised academics.

In this article, Sharon Hartles highlights the high-profile legal battle involving numerous Primodos-affected claimants against pharmaceutical companies and the government. The court ruled against the claimants, dismissing their claims related to hormone pregnancy tests and foetal harm. This decision led to disappointment and criticism from advocates, MPs, and academics involved in the Primodos scandal.

Sharon Hartles is affiliated with the Risky Hormones research project, which is an international collaboration in partnership with patient groups. Additionally, she is a member of the Harm and Evidence Research Collaborative at the Open University.